Mechanism of action
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Research examines combinatorial agonism at GIPR and GLP-1R in pancreatic, adipose, and hepatic tissue models — a newer area of incretin axis research.
Specifications
- Format
- Lyophilized vial
- Size
- 10mg
- Purity
- 98%+ target
- Status
- limited
- Storage
- Lyophilized at −20 °C. Reconstituted: 4 °C, use within 21 days. Single-use aliquoting recommended for sensitive assays.
- Solubility
- Soluble in sterile water at up to 5 mg/mL; slight heating (37 °C) may aid dissolution.
Documentation cues
Premium research categoryLot-level documentationResearch use only
Every lot is batch-tested by an accredited third-party laboratory before release. Certificate of Analysis includes HPLC purity trace, mass spectrometry identity confirmation, and endotoxin result.
View quality architecture →You may also need
Frequently ordered together
